Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Latest, FY2025
16,978
Period ended Dec 31, 2025
Change on a year earlier
-14.9%
19,948 in FY2024
History
17 years
Since FY2009
Sources
16
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Intangible assets, net ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 16,978 | -14.9% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 19,948 | -24.6% | Form 10-K (filed 2025-02-28) ↗ |
| FY2023 | Dec 31, 2023 | 26,454 | -8.4% | Form 10-K (filed 2024-02-23) ↗ |
| FY2022 | Dec 31, 2022 | 28,894 | -13.6% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 33,455 | +1.0% | Form 10-K (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 33,126 | +140.3% | Form 10-K (filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 13,786 | -12.4% | Form 10-K (filed 2020-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 15,738 | -8.0% | Form 10-K (filed 2019-02-26) ↗ |
| FY2017 | Dec 31, 2017 | 17,100 | +90.6% | Form 10-K (filed 2018-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 8,971 | -12.5% | Form 10-K (filed 2017-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 10,247 | -7.5% | Form 10-K (filed 2016-02-24) ↗ |
| FY2014 | Dec 31, 2014 | 11,073 | -6.9% | Form 10-K (filed 2015-02-25) ↗ |
| FY2013 | Dec 31, 2013 | 11,900 | +1.4% | Form 10-K (filed 2015-02-25) ↗ |
| FY2012 | Dec 31, 2012 | 11,736 | +1,004.2% | Form 10-K (filed 2013-02-27) ↗ |
| FY2011 | Dec 31, 2011 | 1,063 | +23.1% | Form 10-Q (filed 2012-05-04) ↗ |
| FY2010 | Dec 31, 2010 | 863 | -6.5% | Form 10-K (filed 2011-02-28) ↗ |
| FY2009 | Dec 31, 2009 | 923 | – | Form 10-Q (filed 2010-08-09) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Intangible assets, net ($M) ($M), annual FY2009–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fs_intang
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.